Ryoichi Ishibashi

Febuxostat does not delay progression of carotid atherosclerosis in patients with asymptomatic hyperuricemia: A randomized, controlled trial

Atsushi Tanaka, Isao Taguchi, Hiroki Teragawa et al. · PLoS Medicine · 2020 · 98 citations · Full text

Association of serum levels of antibodies against MMP1, CBX1, and CBX5 with transient ischemic attack and cerebral infarction

Hao Wang, Xiaomeng Zhang, Go Tomiyoshi et al. · Oncotarget · 2017 · 53 citations · Full text

The reduced form of coenzyme Q10 improves glycemic control in patients with type 2 diabetes: An open label pilot study

Morito Mezawa, Minoru Takemoto, Shunichiro Onishi et al. · BioFactors · 2012 · 43 citations

Comparing the effects of ipragliflozin versus metformin on visceral fat reduction and metabolic dysfunction in Japanese patients with type 2 diabetes treated with sitagliptin: A prospective, multicentre, open‐label, blinded‐endpoint, randomized controlled study (PRIME‐V study)

Masaya Koshizaka, Ko Ishikawa, Ryoichi Ishibashi et al. · Diabetes Obesity and Metabolism · 2019 · 39 citations · Full text

Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic stroke

Takaki Hiwasa, Hao Wang, K Goto et al. · BMC Medicine · 2021 · 28 citations · Full text